Bisoprolol in CAD - Key Insights from National Consensus 2025 with Special Focus on Women Dr. Prem Aggarwal10 July 2025 11:39 AM ISTBisoprolol is reaffirmed as a key cardioselective Beta-1-blocker across the cardiovascular disease (CVD) continuum, with a special focus on its...
Aspirin in Primary Prevention of Stroke-Review of Evidence Through the Needs of Indian Clinical Settings Dr. Rahul R. Patil7 July 2025 11:42 AM ISTIntroduction: Stroke Burden and Aspirin's RoleThe stroke burden in India is substantial and growing, with an incidence of 119-145 per 100,000 annually...
Identifying Candidates for Aspirin in Primary Prevention: Men Aged 40-50 with Hypertension, Dyslipidemia, and Familial ASCVD Risk Dr. Pradeep Haranahalli1 July 2025 11:03 AM ISTPremature ASCVD: Why Age 40-50 Males Need Closer Attention? Premature ASCVD is rising sharply in Indian men aged 40-50, demanding earlier...
Aspirin in Primary Prevention: Prudent Guideline-Based Approach Prof. (Dr.) J.P.S. Sawhney13 Jun 2025 11:44 AM ISTAspirin in Primary Prevention: Need for Delineating High CV-Risk, Low-Bleeding-Risk Profiles: Aspirin in primary prevention requires a nuanced,...
Micro Labs Launches Sitanorm-E, Sitagliptin-Empagliflozin FDC for Uncontrolled Type 2 Diabetes in India Deeksha Bhandari6 Jun 2025 12:11 PM ISTMicro Labs has announced the launch of Sitanorm-E, a fixed-dose combination (FDC) of Sitagliptin and Empagliflozin. The combination is formulated to...
Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates Dr. Milind Desai31 May 2025 10:53 AM ISTPremature ASCVD in IndiaIn India, over 50% of cardiovascular disease (CVD) deaths occur before 50 years, and 25% of myocardial infarction (MI) events...
Ajanta Pharma Launches Met-XL D to Improve Outcomes for Heart Failure and Post-Myocardial Infarction Patients Deeksha Bhandari22 May 2025 12:30 PM ISTAjanta Pharma, one of the leaders in the cardiology segment has launched the fixed dose combination of Metoprolol and Dapagliflozin under the brand...
Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases Dr. Sanjay Mittal14 May 2025 11:37 AM ISTCardiovascular diseases (CVD) account for 24.8% of all deaths in India, with an age-standardized death rate of 272 per 100,000-higher than the global...
Aspirin in Primary Prevention- When to Consider? Dr A B Chandorkar9 May 2025 11:16 AM ISTReframing Aspirin's Role in Primary Prevention: Evolving evidence has refined our understanding of aspirin's role in primary prevention. While earlier...
Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates Dr. Salil Vaidya28 April 2025 10:25 AM ISTCVD Risk in Women After 40: Cardiovascular disease (CVD) is the leading cause of death in individuals with type 2 diabetes (T2D) and hypertension. (1)...
Medical Bulletin 21/ April/ 2025 Dr. Bhumika Maikhuri21 April 2025 3:00 PM ISTHere are the top medical news for the day:Research Links Urinary Incontinence to Heart DiseaseA University of Iowa-led research team has found that...
Research Links Urinary Incontinence to Heart Disease Dr. Garima Soni21 April 2025 8:00 AM ISTA University of Iowa-led research team has found that urinary incontinence may be associated with a greater risk for cardiovascular disease in...
